Abstract:
PURPOSE: A composition containing ginseng extract is provided to significantly suppress prostatic hyperplasia and to remarkably suppress growth of benign prostate tissues. CONSTITUTION: A pharmaceutical composition for preventing or treating prostatic hyperplasia contains extract of ginseng, Rhynchosia Nulubilis, and green tea as an active ingredient. The ginseng extract is prepared by pulverizing 600g of ginseng, adding 12 L of water, performing hot water extraction at 100°C for 3 hours, concentrating in a vacuum condenser at 45°C, and freeze-drying. The Rhynchosia Nulubilis extract is prepared by pulverizing 600g of Rhynchosia Nulubilis, adding 12L of water, performing at 100°C for three hours, concentrating at 45°C, and freeze-drying.
Abstract:
PURPOSE: A pharmaceutical composition containing Eucommia ulmoides extract is provided to ensure anti-inflammation and to develop a agent for preventing and treating rheumatoid arthritis. CONSTITUTION: An Eucommia ulmoides extract has anti-inflammatory activation and osteoclast suppression effect. A pharmaceutical composition for preventing or treating rheumatoid arthritis contains the Eucommia ulmoides extract as an active ingredient. The Eucommia ulmoides extract is a hot water extract of Eucommia ulmoides bark. A health food for preventing or treating rheumatoid arthritis contains the Eucommia ulmoides extract as an active ingredient.
Abstract:
PURPOSE: A composition containing ginseng extract with a nerve protective action is provided to treat and prevent brain-associated diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating nerve diseases contains ginseng extract. The ginseng extract is a crude extract obtained using purified water, ethanol or mixture solvent thereof or non-polar soluble extract obtained using ethanol. The pharmaceutical composition is used in the form of injection formulation, tablet, capsule, liquid or pill. A health food composition for improving brain function contains ginseng extract. The health food composition is used in the form of granule, beverage, gum or tea.
Abstract:
본 발명은 붉나무 줄기로부터 분리된 신규 항암활성 화합물 및 그 제조방법에 관한 것으로, 하기 화학식 1로 표시되는 신규 트리테르펜계 화합물 및 그 제조방법에 관한 것이다. 본 발명의 신규 트리테르펜계 화합물은 탁월한 항암활성을 나타내므로 항암 보조제를 비롯한 신기능성 의약품과 식품 첨가물, 음료 첨가물 및 건강기능식품 등에 유용하게 사용될 수 있다. 화학식 1
Abstract:
PURPOSE: An anticancer compound isolated from Asparagus oligoclonos Maxim. and a purification method thereof are provided. The isolated compound has improved anticancer activity. CONSTITUTION: An anticancer compound is isolated from Asparagus oligoclonos Maxim, and includes (25S)-5β-spirostan-3β, 17α-diol-3-0-β- D-xylopyranosyl-(1→2)- £α -L-rhamnopyranosyl-(1→4)|-β- D-glucopyranoside represented by formula 1. A method for extracting the anticancer compound of the formula 1 comprises the steps of: repeatedly extracting Asparagus oligoclonos Maxim. using an organic solvent, followed by solvent-distribution; and subjecting the extract of Asparagus oligoclonos Maxim. to chromatography.